Search research articles
Contact Us
Filters
Showing results (11-20 of 39) with videos related to
Page
of 4
Sort By:
JAMA
|
May 19, 2005
Life-threatening sepsis associated with adjuvant doxorubicin plus docetaxel for intermediate-risk breast cancer
Etienne G C Brain, Thomas Bachelot, Daniel Serin, et al.
Bulletin Du Cancer
|
August 12, 2018
[Supportive care for survivors]
Grégory Ninot, Philippe Debourdeau, Françoise Blanc-Legier, et al.
Cancer Causes & Control : CCC
|
December 19, 2007
Cancer screening in France: subjects' and physicians' attitudes
François Eisinger, Jean-Yves Blay, Jean-François Morère, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2007
Assessment of care by breast cancer patients participating or not participating in a randomized controlled trial: a report with the Patients' Committee for Clinical Trials of the Ligue Nationale Contre le Cancer
Claire Julian-Reynier, Jean Genève, Florence Dalenc, et al.
Bulletin Du Cancer
|
October 9, 2014
[Bevacizumab and taxanes in the first-line treatment of metastatic breast cancer : overall survival and subgroup analyses of the ATHENA study in France]
Jean-Yves Pierga, Rémy Delva, Xavier Pivot, et al.
BMC Cancer
|
April 17, 2008
Impact of organised programs on colorectal cancer screening
François Eisinger, Laurent Cals, Anne Calazel-Benque, et al.
Contemporary Clinical Trials
|
April 17, 2007
Decision-making and breast cancer clinical trials: how experience challenges attitudes
Julien Mancini, Jean Genève, Florence Dalenc, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 24, 2007
Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast-conserving surgery? Results of the ARCOSEIN multicenter, Phase III study: patients' and doctors' views
Alain H Toledano, Marc A Bollet, Alain Fourquet, et al.
Anti-Cancer Drugs
|
March 8, 2006
Phase II study of an oxaliplatin/vinorelbine combination in patients with anthracycline- and taxane-pre-treated metastatic breast cancer
Thierry Petit, Abdellatif Benider, Alejandro Yovine, et al.
Bulletin Du Cancer
|
June 6, 2012
[Safety and efficacy of bevacizumab combined with taxanes in the first-line treatment of metastatic breast cancer: ATHENA study-France]
Anne-Claire Hardy-Bessard, Rémy Delva, Xavier Pivot, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 39) with videos related to
Sort By:
Page
of 4
JAMA
|
May 19, 2005
Life-threatening sepsis associated with adjuvant doxorubicin plus docetaxel for intermediate-risk breast cancer
Etienne G C Brain, Thomas Bachelot, Daniel Serin, et al.
Bulletin Du Cancer
|
August 12, 2018
[Supportive care for survivors]
Grégory Ninot, Philippe Debourdeau, Françoise Blanc-Legier, et al.
Cancer Causes & Control : CCC
|
December 19, 2007
Cancer screening in France: subjects' and physicians' attitudes
François Eisinger, Jean-Yves Blay, Jean-François Morère, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2007
Assessment of care by breast cancer patients participating or not participating in a randomized controlled trial: a report with the Patients' Committee for Clinical Trials of the Ligue Nationale Contre le Cancer
Claire Julian-Reynier, Jean Genève, Florence Dalenc, et al.
Bulletin Du Cancer
|
October 9, 2014
[Bevacizumab and taxanes in the first-line treatment of metastatic breast cancer : overall survival and subgroup analyses of the ATHENA study in France]
Jean-Yves Pierga, Rémy Delva, Xavier Pivot, et al.
BMC Cancer
|
April 17, 2008
Impact of organised programs on colorectal cancer screening
François Eisinger, Laurent Cals, Anne Calazel-Benque, et al.
Contemporary Clinical Trials
|
April 17, 2007
Decision-making and breast cancer clinical trials: how experience challenges attitudes
Julien Mancini, Jean Genève, Florence Dalenc, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 24, 2007
Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast-conserving surgery? Results of the ARCOSEIN multicenter, Phase III study: patients' and doctors' views
Alain H Toledano, Marc A Bollet, Alain Fourquet, et al.
Anti-Cancer Drugs
|
March 8, 2006
Phase II study of an oxaliplatin/vinorelbine combination in patients with anthracycline- and taxane-pre-treated metastatic breast cancer
Thierry Petit, Abdellatif Benider, Alejandro Yovine, et al.
Bulletin Du Cancer
|
June 6, 2012
[Safety and efficacy of bevacizumab combined with taxanes in the first-line treatment of metastatic breast cancer: ATHENA study-France]
Anne-Claire Hardy-Bessard, Rémy Delva, Xavier Pivot, et al.
Page
of 4